Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Entropic Biosciences has developed a proprietary technology that enables the rapid assembly of functional human tissues and organoids from multiple cell types within 24 hours. Their chemically defined, plant-based biomaterial is 3D printable and animal-free. The technology is positioned as a tool for drug discovery, life sciences research, food security applications, and potentially personalized medicine by creating patient-specific tissue models. The company has received recognition from the National Inventors Hall of Fame Collegiate Inventors Competition and holds a patent acceleration certificate from the USPTO
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Entropic Biosciences.